HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Cypendazole

HCID 34280
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
28559-00-4
Standard SMILES
COC(=O)Nc1nc2ccccc2n1C(=O)NCCCCCC#N
InChIKey
MKZGVGOBXZJKGV-UHFFFAOYSA-N
Molecular formula
C16H19N5O3
Average molar mass
329.35 g/mol
Monoisotopic mass
329.14878949

Overview

Cypendazole is a benzimidazole fungicide and a benzimidazolylcarbamate fungicide.

Names & identifiers

Preferred name
Cypendazole
IUPAC
methyl N-[1-(5-cyanopentylcarbamoyl)benzimidazol-2-yl]carbamate
English name
methyl [1-[[(5-cyanopentyl)amino]carbonyl]-1H-benzimidazol-2-yl]carbamate
Molecular formula
C16H19N5O3
Molecular weight
329.35

Names & synonyms

CypendazoleCypendazol28559-00-4SL67GU815EBAY-6233Methyl 1-(5-cyanopentylcarbamoyl)benzimidazol-2-ylcarbamateDAM-18654DTXSID3041825BAY-6233ACarbamic acid, (1-(((5-cyanopentyl)amino)carbonyl)-1H-benzimidazol-2-yl)-, methyl esterRefChem:1082801DTXCID1021825
Show more names
N-[1-(5-Cyanopentylcarbamoyl)-1H-benzimidazol-2-yl]carbamic acid methyl esterCarbamic acid, N-[1-[[(5-cyanopentyl)amino]carbonyl]-1H-benzimidazol-2-yl]-, methyl ester
methyl N-(1-((5-cyanopentyl)carbamoyl)-1H-1,3-benzodiazol-2-yl)carbamate249-082-1Cypendazole [ISO]Methyl (1-(((5-cyanopentyl)amino)carbonyl)-1H-benzimidazol-2-yl)carbamateBAY 6233METHYL [1-[[(5-CYANOPENTYL)AMINO]CARBONYL]-1H-BENZIMIDAZOL-2-YL]CARBAMATEBAY 6233aBAY-DAM 18654

Database identifiers

CAS
28559-00-4
PubChem CID
34280
DTXSID
DTXSID3041825
ChEBI

Properties

Computed structural properties

XLogP
1.6
Topological polar surface area
109 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
5
Rotatable bonds
7
Heavy atoms
24
Formal charge
0
Complexity
489

Physicochemical properties

FDA UNII
67 GU815E · SL67GU815E
EPA Substance Registry System
Cypendazole (28559-00-4)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Treatment · 1 item

If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium bicarbonate. For skin contact, the skin should be washed with soap and water. If the compound has entered the eyes, they should be washed with large quantities of isotonic saline or water. In serious cases, atropine and/or pralidoxime should be administered. Anti-cholinergic drugs work to counteract the effects of excess acetylcholine and reactivate AChE. Atropine can be used as an antidote in conjunction with pralidoxime or other pyridinium oximes (such as trimedoxime or obidoxime), though the use of '-oximes' has been found to be of no benefit, or possibly harmful, in at least two meta-analyses. Atropine is a muscarinic antagonist, and thus blocks the action of acetylcholine peripherally.

Health Effects · 1 item

Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Chronically high (>10 years) exposure leads to neuropsychological consequences including disturbances in perception and visuo-motor processing (A15321).

Exposure Routes

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

The carbamates are hydrolyzed enzymatically by the liver; degradation products are excreted by the kidneys and the liver. (L793) Organic nitriles are converted into cyanide ions through the action of cytochrome P450 enzymes in the liver. Cyanide is rapidly absorbed and distributed throughout the body. Cyanide is mainly metabolized into thiocyanate by either rhodanese or 3-mercaptopyruvate sulfur transferase. Cyanide metabolites are excreted in the urine. (L96)

Uses & manufacturing

UsesCypendazole is widely used as an insecticide or pesticide in homes, gardens and agricultural applications. It is a synthetic compound.

Applications

DescriptionCypendazole is an obsolete fungicide. Little data is available regarding its environmental fate, ecotoxicology or impact on human health.

Suppliers2 total

上海杰股生物科技有限公司021-51698675 · [email protected]
DAYANG CHEM (HANGZHOU) CO.,LTD+86-88938639 +86-17705817739 · [email protected]

Additional notes

DefinitionChEBI: Cypendazole is a benzimidazole fungicide and a benzimidazolylcarbamate fungicide.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
CHEBI:82059
UNII
SL67GU815E
EC Number
249-082-1
Nikkaji
J21.577E
Inhalation (L793) ; oral (L793); dermal (L793)
Toxicity Summary · 1 item

Cypendazole is a cholinesterase or acetylcholinesterase (AChE) inhibitor. Carbamates form unstable complexes with chlolinesterases by carbamoylation of the active sites of the enzymes. This inhibition is reversible. A cholinesterase inhibitor suppresses the action of acetylcholine esterase. Because of its essential function, chemicals that interfere with the action of acetylcholine esterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop.

Signs and Symptoms · 1 item

As with organophosphates, the signs and symptoms are based on excessive cholinergic stimulation. Unlike organophosphate poisoning, carbamate poisonings tend to be of shorter duration because the inhibition of nervous tissue acetylcholinesterase is reversible, and carbamates are more rapidly metabolized. Muscle weakness, dizziness, sweating and slight body discomfort are commonly reported early symptoms. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Contraction of the pupils with blurred vision, incoordination, muscle twitching and slurred speech have been reported. (L795)

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).